| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0004 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.0004 |